Moderna, Inc. (MRNA)
150.80
-3.47
(-2.25%)
USD |
NASDAQ |
Sep 02, 16:00
150.50
-0.30
(-0.20%)
After-Hours: 17:48
Moderna Research and Development Expense (Annual) : 2.917B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.917B |
| December 31, 2024 | 4.354B |
| December 31, 2023 | 4.224B |
| December 31, 2022 | 2.947B |
| December 31, 2021 | 1.759B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.339B |
| December 31, 2019 | 465.29M |
| December 31, 2018 | 509.68M |
| December 31, 2017 | 410.46M |
| December 31, 2016 | 274.72M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 1.493B |
| BioNTech SE | 2.376B |
| Kailera Therapeutics, Inc. | 109.11M |
| Twist Bioscience Corp. | 80.28M |
| Revolution Medicines, Inc. | 978.68M |